The ESMO Immuno-Oncology Congress helps to increase the overall understanding of the potential of immunotherapy and its implications for clinical practice, today and in the future.
The Congress keeps oncologists up-to-date in this rapidly evolving field and is the ideal platform for all interested stakeholders. From the basics of immunotherapies to the latest research results; from understanding different treatment options to management of toxicities and interpretation of new data, the Congress builds the European community of immuno-oncology stakeholders